These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37754821)

  • 1. Shared Decision Making and Cardioneuroablation Allow Discontinuation of Permanent Pacing in Patients with Vagally Mediated Bradycardia.
    Stec S; Wileczek A; Reichert A; Śledź J; Kosior J; Jagielski D; Polewczyk A; Zając M; Kutarski A; Karbarz D; Zyśko D; Nowarski Ł; Stodółkiewicz-Nowarska E
    J Cardiovasc Dev Dis; 2023 Sep; 10(9):. PubMed ID: 37754821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of cardioneuroablation with and without extra-cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope.
    Pachon-M JC; Pachon-M EI; Pachon CTC; Santillana-P TG; Lobo TJ; Pachon-M JC; Higuti C; Zerpa-A JC; Pachon MZC; Ortencio FA; Osorio TG; Peixoto LA
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):641-650. PubMed ID: 38240356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Symptomatic Functional Atrioventricular Block by Cardioneuroablation as an Alternative to Pacemaker Implantation.
    Pachon-M JC; Ortencio FA; Pachon-M EI; Lobo T; Santillana-P TG; Pachon CT; Cunha-P MZ; Pachon-M JCM; Zerpa-A JC; Amarante RC
    JACC Case Rep; 2022 Aug; 4(15):990-995. PubMed ID: 35935156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study.
    Han Y; Shao M; Yang H; Sun H; Sang W; Wang L; Wang L; Yang S; Jian Y; Tang B; Li Y
    Sci Rep; 2024 Mar; 14(1):5926. PubMed ID: 38467744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioneuroablation for pediatric patients with functional sinus node dysfunction and paroxysmal atrioventricular block.
    Choi NH; Hong J; Moak JP
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):221-229. PubMed ID: 38038245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent pacing versus cardioneuroablation for cardioinhibitory vasovagal syncope.
    Gopinathannair R; Olshansky B; Turagam MK; Gautam S; Futyma P; Akella K; Tanboga HI; Bozyel S; Yalin K; Padmanabhan D; Shenthar J; Lakkireddy D; Aksu T
    J Interv Card Electrophysiol; 2022 Dec; ():. PubMed ID: 36562915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of aging on outcomes of cardioneuroablation for reflex syncope or functional bradycardia: Results from the cardionEuroabLation: patiEnt selection, imaGe integrAtioN and outComEs-The ELEGANCE multicenter study.
    Francia P; Viveros D; Falasconi G; Penela D; Soto-Iglesias D; Martí-Almor J; Alderete J; Saglietto A; Bellido AF; Franco-Ocaña P; Zaraket F; Matiello M; Fernández-Armenta J; San Antonio R; Berruezo A
    Heart Rhythm; 2023 Sep; 20(9):1279-1286. PubMed ID: 37329936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracardiac Vagal Stimulation-Assisted Cardioneuroablation: Dynamically Evaluating the Impact of Sequential Ganglionated Plexus Ablation on Vagal Control of SAN and AVN in Patients with Sinoatrial Node Dysfunction.
    Chen W; Liu Z; Xiao P; Xu Y; Li D; Xiong Q; Zou L; Qin F; Tao X; Chen J; Lan X; Du H; Yin Y; Ling Z
    J Cardiovasc Dev Dis; 2022 Jun; 9(6):. PubMed ID: 35735817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.
    Aksu T; Chung MK
    Curr Cardiovasc Risk Rep; 2024 Apr; 18(4):55-64. PubMed ID: 38707611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation.
    Aksu T; Guler TE; Bozyel S; Yalin K; Gopinathannair R
    Europace; 2020 Sep; 22(9):1320-1327. PubMed ID: 32898255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-term results of cardioneuroablation for clinical bradyarrhythmias and vasovagal syncope: effects on QT interval and heart rate.
    Aksu T; Guler TE; Bozyel S; Golcuk SE; Yalin K; Lakkireddy D; Gopinathannair R
    J Interv Card Electrophysiol; 2021 Jan; 60(1):57-68. PubMed ID: 32034611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope.
    Joza J; Gustavo Bravosi da Rosa L; Alturki A; Anglesio V; Sanchez-Somonte P; Poletaev V; Bernier M; Verma A; Essebag V
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101360. PubMed ID: 38379634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life.
    Traykov V; Shalganov T
    Curr Cardiol Rep; 2023 Dec; 25(12):1839-1849. PubMed ID: 37982935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study.
    Aksu T; Padmanabhan D; Shenthar J; Yalin K; Gautam S; Valappil SP; Banavalikar B; Guler TE; Bozyel S; Tanboga IH; Lakkireddy D; Olshansky RB; Gopinathannair R
    J Interv Card Electrophysiol; 2022 Jan; 63(1):77-86. PubMed ID: 33527216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a cross-sectional observational study.
    Aksu T; Guler TE; Mutluer FO; Bozyel S; Golcuk SE; Yalin K
    J Interv Card Electrophysiol; 2019 Mar; 54(2):177-188. PubMed ID: 30054828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.
    Aksu T; Tung R; De Potter T; Markman TM; Santangeli P; du Fay de Lavallaz J; Winterfield JR; Baykaner T; Alyesh D; Joza JE; Gopinathannair R; Badertscher P; Do DH; Hussein A; Osorio J; Dewland T; Perino A; Rodgers AJ; DeSimone C; Alfie A; Atwater BD; Singh D; Kumar K; Salcedo J; Bradfield JS; Upadhyay G; Sood N; Sharma PS; Gautam S; Kumar V; Forno ARJD; Woods CE; Rav-Acha M; Valeriano C; Kapur S; Enriquez A; Sundaram S; Glikson M; Gerstenfeld E; Piccini J; Tzou WS; Sauer W; d'Avila A; Shivkumar K; Huang HD
    J Interv Card Electrophysiol; 2024 Mar; ():. PubMed ID: 38499825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioneuroablation for successful treatment of symptomatic bradycardia in a 12-year-old child after a 6-month follow-up.
    Xu X; He S; Liu Q; Liu R; Zhang L; Chen W; Yin Y; Lu T
    Front Cardiovasc Med; 2023; 10():1290482. PubMed ID: 38099231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioneuroablation in the Management of Vasovagal Syncope, Sinus Node Dysfunction and Functional Atrioventricular Block: Patient Selection Based on Supporting Evidence.
    Aksu T; Erdem Guler T
    J Atr Fibrillation; 2020; 13(1):2396. PubMed ID: 33024497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with a bradycardia indicating pacemaker.
    Rosenqvist M; Edhag KO; Vallin HO
    Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):515-24. PubMed ID: 6191288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.
    Piotrowski R; Baran J; Sikorska A; Krynski T; Kulakowski P
    JACC Clin Electrophysiol; 2023 Jan; 9(1):85-95. PubMed ID: 36114133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.